Clinical Presentation and Treatment Outcome of Sleeping Sickness in Sudanese Pre-School Children.
AffiliationMédecins Sans Frontières, Rue de Lausanne 78, 1202 Geneva, Switzerland.
MetadataShow full item record
AbstractBACKGROUND: Existing data on human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense among children are limited. Here, we described the demographic, clinical, diagnostic, treatment and outcome characteristics of HAT in pre-school children from Kajo-Keji County, South Sudan in comparison with older patients. METHODS: We did a retrospective analysis of HAT patients treated at the Kiri Sleeping Sickness Treatment Centre (SSTC), Kajo-Keji County, from June 2000 to December 2002. RESULTS: Of 1958 HAT patients, 119 (6.1%) were pre-school children (<6 years) including 56 (47%) in first-stage illness and 63 (53%) in second-stage. The proportion of children in second-stage HAT was significantly higher in very young children (<2 years). Walking and speech disturbances were more frequent in second-stage HAT but other neurological symptoms and signs were not associated with disease stage. Pentamidine treatment for first-stage illness was very safe and effective among pre-school children. In contrast, 4.9% of pre-school children in second-stage illness died during melarsoprol treatment and 46% had > or = 1 severe adverse event(s). Macular rash, jaundice and skin necrosis on injection site were significantly more frequent in this age group (p<0.05). Melarsoprol-induced encephalopatic syndrome was less frequent but more severe than in older age groups. CONCLUSION: The clinical features of T. b. gambiense HAT among pre-school children are insufficiently stage-specific. Therefore, laboratory-based staging is mandatory to prevent unnecessary harm to HAT patients caused by the high toxicity of melarsoprol.
- Treatment outcomes and risk factors for relapse in patients with early-stage human African trypanosomiasis (HAT) in the Republic of the Congo.
- Authors: Balasegaram M, Harris S, Checchi F, Hamel C, Karunakara U
- Issue date: 2006 Oct
- Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
- Authors: Balasegaram M, Young H, Chappuis F, Priotto G, Raguenaud ME, Checchi F
- Issue date: 2009 Mar
- Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
- Authors: Buguet A, Bisser S, Josenando T, Chapotot F, Cespuglio R
- Issue date: 2005 Jan
- An alternative form of melarsoprol in sleeping sickness.
- Authors: Kennedy PG
- Issue date: 2012 Aug
- The phenomenon of treatment failures in Human African Trypanosomiasis.
- Authors: Brun R, Schumacher R, Schmid C, Kunz C, Burri C
- Issue date: 2001 Nov